ES461388A1 - Un procedimiento para la preparacion de un compuesto de pi- rrolidona. - Google Patents

Un procedimiento para la preparacion de un compuesto de pi- rrolidona.

Info

Publication number
ES461388A1
ES461388A1 ES461388A ES461388A ES461388A1 ES 461388 A1 ES461388 A1 ES 461388A1 ES 461388 A ES461388 A ES 461388A ES 461388 A ES461388 A ES 461388A ES 461388 A1 ES461388 A1 ES 461388A1
Authority
ES
Spain
Prior art keywords
phenyl
alkyl
carbon atoms
tetrazol
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES461388A
Other languages
English (en)
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc filed Critical Pfizer Inc
Publication of ES461388A1 publication Critical patent/ES461388A1/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24Oxygen or sulfur atoms
    • C07D207/262-Pyrrolidones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
ES461388A 1976-08-06 1977-08-05 Un procedimiento para la preparacion de un compuesto de pi- rrolidona. Expired ES461388A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US71236276A 1976-08-06 1976-08-06

Publications (1)

Publication Number Publication Date
ES461388A1 true ES461388A1 (es) 1978-12-01

Family

ID=24861795

Family Applications (2)

Application Number Title Priority Date Filing Date
ES461388A Expired ES461388A1 (es) 1976-08-06 1977-08-05 Un procedimiento para la preparacion de un compuesto de pi- rrolidona.
ES471349A Expired ES471349A1 (es) 1976-08-06 1978-07-01 Un procedimiento para la preparacion de un compuesto de pi- rrolidona

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES471349A Expired ES471349A1 (es) 1976-08-06 1978-07-01 Un procedimiento para la preparacion de un compuesto de pi- rrolidona

Country Status (31)

Country Link
JP (2) JPS5321159A (2)
AR (1) AR217080A1 (2)
AT (1) AT362887B (2)
AU (1) AU508007B2 (2)
BE (1) BE857506A (2)
BG (1) BG31073A3 (2)
CA (1) CA1077948A (2)
CH (1) CH624934A5 (2)
CS (1) CS221269B2 (2)
DD (2) DD136135A5 (2)
DE (1) DE2735904A1 (2)
DK (1) DK352077A (2)
ES (2) ES461388A1 (2)
FI (1) FI70009C (2)
FR (1) FR2369260A1 (2)
GB (2) GB1556569A (2)
GR (1) GR68688B (2)
HU (1) HU180273B (2)
IE (1) IE45505B1 (2)
IL (1) IL52615A (2)
LU (1) LU77936A1 (2)
NL (1) NL7708637A (2)
NO (1) NO772752L (2)
NZ (1) NZ184806A (2)
PH (1) PH17398A (2)
PL (2) PL200124A1 (2)
PT (1) PT66891B (2)
SE (1) SE423813B (2)
SU (3) SU703016A3 (2)
YU (1) YU192577A (2)
ZA (1) ZA774704B (2)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5695569A (en) * 1979-12-27 1981-08-03 Canon Inc Forming method for bar lens sphere face
US4321201A (en) * 1980-09-22 1982-03-23 E. I. Du Pont De Nemours And Company Optically active tert-alkyl 7-(2-oxo-5-carbonyloxypyrrolidinyl) heptanoates
IL141120A0 (en) * 2000-01-31 2002-02-10 Pfizer Prod Inc Use of prostaglandin (pge2) receptor 4 (epa) selective agonists for the treatment of acute and chronic renal failure
AU2001290250A1 (en) * 2000-09-21 2002-04-02 Ono Pharmaceutical Co. Ltd. Ep4 receptor agonists containing 8-azaprostaglandin derivatives as the active ingredient
OA12533A (en) * 2000-11-27 2006-06-05 Pfizer Prod Inc Ep4 receptor selective agonists in the treatment of osteoporosis.
EP2255829A3 (en) * 2001-07-23 2012-03-28 Ono Pharmaceutical Co., Ltd. Pharmaceutical composition for treatment of diseases associated with decrease in bone mass comprising EP4 agonist as active ingredient
WO2003077910A1 (en) * 2002-03-18 2003-09-25 Pfizer Products Inc. Methods of treatment with selective ep4 receptor agonists
US6573294B1 (en) 2002-05-14 2003-06-03 Allergan, Inc. 8-azaprostaglandin analogs as agents for lowering intraocular pressure
US7256211B1 (en) * 2003-01-21 2007-08-14 Ono Pharmaceutical Co., Ltd. 8-azaprostaglandin derivatives and medical use thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1386146A (en) * 1972-05-03 1975-03-05 Ici Ltd Cyclopentane derivatives
JPS511460A (en) * 1974-06-24 1976-01-08 Tanabe Seiyaku Co 22 piroridonjudotaino seiho
JPS514166A (ja) * 1974-06-28 1976-01-14 Tanabe Seiyaku Co 22piroridonjudotaino seiho
US3975399A (en) * 1974-08-06 1976-08-17 E. I. Du Pont De Nemours And Company 1,5-Disubstituted-2-pyrrolidinones, -3-pyrrolin-2-ones, and -4-pyrrolin-2-ones
DE2528664A1 (de) * 1975-06-27 1977-01-13 Hoechst Ag Pyrrolidone und verfahren zu ihrer herstellung

Also Published As

Publication number Publication date
GB1556570A (en) 1979-11-28
FR2369260B1 (2) 1982-02-12
GB1556569A (en) 1979-11-28
CS221269B2 (en) 1983-04-29
FI70009B (fi) 1986-01-31
PT66891B (en) 1979-01-26
LU77936A1 (2) 1978-04-27
SU850000A3 (ru) 1981-07-23
SU703016A3 (ru) 1979-12-05
NZ184806A (en) 1980-04-28
SU818480A3 (ru) 1981-03-30
IE45505L (en) 1978-02-06
JPS5531147B2 (2) 1980-08-15
ZA774704B (en) 1978-06-28
YU192577A (en) 1983-04-30
SE423813B (sv) 1982-06-07
CA1077948A (en) 1980-05-20
NL7708637A (nl) 1978-02-08
PL200124A1 (pl) 1978-05-22
PH17398A (en) 1984-08-08
FI70009C (fi) 1986-09-12
DK352077A (da) 1978-02-07
JPS5555161A (en) 1980-04-22
SE7708642L (sv) 1978-02-07
DD136135A5 (de) 1979-06-20
ES471349A1 (es) 1979-09-16
CH624934A5 (2) 1981-08-31
PL112931B1 (en) 1980-11-29
AT362887B (de) 1981-06-25
NO772752L (no) 1978-02-07
GR68688B (2) 1982-02-01
FI772376A7 (2) 1978-02-07
DE2735904A1 (de) 1978-02-09
JPS5321159A (en) 1978-02-27
BE857506A (fr) 1978-02-06
PT66891A (en) 1977-09-01
FR2369260A1 (fr) 1978-05-26
IE45505B1 (en) 1982-09-08
DD143768A5 (de) 1980-09-10
HU180273B (en) 1983-02-28
AU2751577A (en) 1979-02-08
AU508007B2 (en) 1980-03-06
AR217080A1 (es) 1980-02-29
IL52615A0 (en) 1977-10-31
ATA579477A (de) 1980-11-15
JPS585196B2 (ja) 1983-01-29
IL52615A (en) 1981-09-13
BG31073A3 (bg) 1981-10-15

Similar Documents

Publication Publication Date Title
AR245447A1 (es) Procedimiento para preparar derivados de 2,4-diamino-5-(biciclo-sustituido)metilpirimidinas.
ES475240A1 (es) Un procedimiento de compuestos polienicos.
ES481220A1 (es) Un procedimiento para la preparacion de 2-aril-aminotiazo- les.
CO4920223A1 (es) Derivados de 1,3,8-triaza-espiro[4,5]decan-4-ona 8- sustituidos
GB1298577A (en) New stilbene derivatives
ES2107698T3 (es) Benzoilguanidinas sustituidas, procedimiento para su preparacion, su utilizacion como medicamento, como inhibidores del intercambio celular de na+/h+ o como agente de diagnostico, asi como medicamento que las contiene.
ES2139943T3 (es) Nuevos inhibidores de la sintasa de prostaglandina.
ES461388A1 (es) Un procedimiento para la preparacion de un compuesto de pi- rrolidona.
EP0632031A4 (2)
ES2137154T3 (es) Boratos bis-(aciloxi-o) del acido (6,7-sustituido-8-alcoxi-1-ciclopropil-1,4-dihidro-4-oxo-3-quinolinocarboxilico-o3,o4 y sus sales, y metodos para su preparacion.
ES456279A1 (es) Un procedimiento para preparar compuestos de cetofosfonato.
ES433047A1 (es) Un procedimiento para preparar productos intermedios de prostaglandinas.
GB2123830A (en) Trisubstituted diazo compounds
ES449096A1 (es) Un procedimiento para la preparacion de 11-desoxi-16-ariloxi-omega-tetranorprostaglandinas.
ES2054502T3 (es) Esteres del acido 10-(1-hidroxietil)-11-oxo-1-azatriciclo(7.2.0.0(3.8))-undec-2-en-2-carboxilico y un procedimiento para su preparacion.
ES453632A1 (es) Procedimiento para la obtencion de derivados del acido 4-(a-minoacetil) fenoxiacetico.
JPS5419931A (en) Separation of threo, erythro-3-(3,4-dibenzyloxyphenyl)serines
ES464045A1 (es) Un procedimiento para la produccion de una gamma-pirona.
ES2075365T3 (es) Procedimiento para la preparacion de derivados de 3-alcoximetil cefalosporina.
JPS5227791A (en) Synthesis of cephalosporins
ATE191483T1 (de) Trizyklische oximether, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen
GB1429039A (en) Dialkylphosphinyl compounds
ES396073A1 (es) Procedimiento para la obtencion de derivados de la quinoli-na.
ES456379A1 (es) Un procedimiento de resolucion de una mezcla de un compuestode alamina.
ES502668A0 (es) Procedimiento para preparar una solucion hidrocarbonada de un compuesto de alquilsodio

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19981103